PACTR202305893513285Not yet recruitingUnknown
Contexts and social groups specific, multistage, adaptable by inductive studies- randomised controlled social experiment of a biomedical research literacy program for clinical trials' participants and their social network at CERMEL and other stakeholders in Gabon
CERME0 sites195 target enrollmentStarted: May 12, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 195
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 13 Year(s) to 18 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Willingness to participate and to invite one to two members of the social networks
- •Signed informed consent
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Not Applicable
MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND CLINICAL TRIAL OF SUPERIORITY IN EFFICACY AND SAFETY OF THE FIXED-DOSE COMBINATION OF AMOXICILLIN AND AMBROXOL (AMBROXIL®) VERSUS AMOXICILLIN IN THE TREATMENT OF ACUTE BACTERIAL PHARYNGITIS IN THE PEDIATRIC POPULATION.PER-062-20Instituto Quimioterapico S.A.,292
Recruiting
Not Applicable
MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND, CLINICAL TRIAL OF SUPERIORITY IN EFFICACY AND SAFETY OF THE FIXED-DOSE COMBINATION OF AMOXICILLIN AND AMBROXOL (AMBROXIL®) VERSUS AMOXICILLIN IN THE TREATMENT OF ACUTE BACTERIAL PHARYNGOTONSILLITIS IN ADULTS.-J039 Acute tonsillitis, unspecifiedAcute tonsillitis, unspecifiedJ039PER-104-20Instituto Quimioterapico S.A.,14
Recruiting
Not Applicable
MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND CLINICAL TRIAL OF SUPERIORITY IN EFFICACY AND SAFETY OF THE FIXED-DOSE COMBINATION OF CEPHALEXIN AND AMBROXOL (BIOBRONCOL®) VERSUS CEPHALEXIN IN THE TREATMENT OF ACUTE BACTERIAL PHARYNGOTONSILLITIS IN ADULTS-J039 Acute tonsillitis, unspecifiedAcute tonsillitis, unspecifiedJ039PER-103-20Instituto Quimioterapico S.A.,25
Active, not recruiting
Not Applicable
Multicenter, randomized, parallel groups, semi-cross over, open Phase IIIB trial to evaluate treatment compliance for subglossal specific Immunotherapy oral lyophilisate tablets GrazaxR in patients suffering from allergic rhinoconjunctivitis caused by grass pollen - NDEUCTR2006-004820-35-ITALK-ABELLO
Active, not recruiting
Phase 1
Clinical study in early PD patients to investigate the effect of Opicapone 50mg or Levodopa 100 mg in the treatment of motor fluctuations.Parkinson's Disease (PD)MedDRA version: 20.0Level: HLTClassification code 10034005Term: Parkinson's disease and parkinsonismSystem Organ Class: 100000004852EUCTR2020-002754-24-ITBIAL-Portela & Ca, S.A.100